Search

everythinglearnresearchcommunity

for

Search:↓

Bilateral ovarian hyperthecosis is a rare but treatable cause of increased facial hair in postmenopausal women.

Fulvestrant solution doesn't help hair loss in men and postmenopausal women.

Topical DHEA safely increases skin oil production.

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.

Minoxidil helps increase hair growth and density in people with hair loss, with higher concentrations giving better results.

Female androgenic alopecia causes hair thinning in women, especially after menopause, and affects their mental well-being.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Isolated long hairs at the original hairline can help diagnose Frontal Fibrosing Alopecia.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Stopping sunscreen use on the forehead led to hair regrowth in a woman with frontal fibrosing alopecia.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Postmenopausal women with hair loss should get proper tests and consider treatments like minoxidil.

Men and premenopausal women in Korea show different patterns in iron and vitamin D levels, with no clear pattern for postmenopausal women.

Postmenopausal women may experience frontal hairline and eyebrow loss due to cicatricial fibrosis.

New treatments for Frontal Fibrosing Alopecia show promise, especially finasteride and dutasteride, with most patients seeing improvement or stabilization.

Frontal fibrosing alopecia in postmenopausal women can be managed with early treatment using corticosteroids to stop hair loss.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Smoking doesn't cause or prevent Frontal Fibrosing Alopecia, hormonal imbalance may be involved, and a combination of antiandrogens and steroids can help stabilize the condition.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Iron deficiency is common in women regardless of hair loss, and treating it does not usually reverse hair loss.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Finasteride works for male hair loss only.

Dermatologists should carefully choose treatments for FFA to avoid worsening the condition.